翻訳と辞書 |
Abbott v. Sandoz : ウィキペディア英語版 | Abbott v. Sandoz Abbott v. Sandoz was a US patent law case argued before the United States Court of Appeals for the Federal Circuit that established a bright-line ruling regarding claims of patent infringement relating to disagreements over so-called "product-by-process" claims. The case was decided on May 18, 2009. ==Background==
Abbott Labs had a patent on a specific drug called Omnicef used to combat ear infections. Lupin Limited had a court rule that a generic form of Omnicef it produced did not infringe on Abbott's patent since their process to make the drug was different. After the court had ruled in Lupin's favor, Abbott appealed and the case was combined with several other legal suits against smaller pharmaceutical companies, and thus was renamed Abbott v. Sandoz. The federal court affirmed the lower court's decision.〔〔〔
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Abbott v. Sandoz」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|